Suk San Choi; Eunkyeong Jang; Yeon-Kyung Oh; Kiseok Jang; Mi-La Cho; Sung-Hwan Park; Jeehee Youn

doi:10.4110/in.2019.19.e7

Journal List > Immune Netw > v.19(1) > 1117001

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Choi, Jang, Oh, Jang, Cho, Park, and Youn: Aged Sanroque Mice Spontaneously Develop Sjögren's Syndrome-like Disease

Brief Communication

Immune Network 2019; 19(1): e7.

Published online: 1 February 2019

DOI: https://doi.org/10.4110/in.2019.19.e7

Aged Sanroque Mice Spontaneously Develop Sjögren's Syndrome-like Disease

Suk San Choi¹

, Eunkyeong Jang¹, Yeon-Kyung Oh¹, Kiseok Jang², Mi-La Cho³

, Sung-Hwan Park⁴, Jeehee Youn¹

¹Laboratory of Autoimmunology, Department of Anatomy and Cell Biology, Hanyang University College of Medicine, Seoul 04763, Korea.

²Department of Pathology, Hanyang University College of Medicine, Seoul 04763, Korea.

³Department of Medical Life Science, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

⁴Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

Correspondence to Jeehee Youn. Laboratory of Autoimmunology, Department of Anatomy and Cell Biology, Hanyang University College of Medicine, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea. jhyoun@hanyang.ac.kr

Received 20 October 2018 Revised 28 January 2019 Accepted 29 January 2019

The Korean Association of Immunologists

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Sjögren's syndrome (SS) is a chronic inflammatory autoimmune disorder that affects mainly salivary and lacrimal glands, but its cause remains largely unknown. Clinical data indicating that SS occurs in a substantial proportion of patients with lupus points to common pathogenic mechanisms underlying the two diseases. To address this idea, we asked whether SS develops in the lupus-prone mouse strain sanroque (SAN). Owing to hyper-activation of follicular helper T (Tfh) cells, female SAN mice developed lupus-like symptoms at approximately 20 wk of age but there were no signs of SS at that time. However, symptoms typical of SS were evident at approximately 40 wk of age, as judged by reduced saliva flow rate, sialadenitis, and IgG deposits in the salivary glands. Increases in serum titers of SS-related autoantibodies and numbers of autoantibody-secreting cells in cervical lymph nodes (LNs) preceded the pathologic manifestations of SS and were accompanied by expansion of Tfh cells and their downstream effector cells. Thus, our results suggest that chronic dysregulation of Tfh cells in salivary gland-draining LNs is sufficient to drive the development of SS in lupus-prone mice.

Keywords: Sjögren's syndrome, Animal disease models, Systemic lupus erythematosus, Autoimmunity, Follicular helper T cell

Abbreviations

APC

allophycocyanin

cLN

cervical lymph node

Foxp3⁺

forkhead box P3

germinal center

lymph node

M3R

muscarinic receptor type 3

rheumatoid arthritis

SAN

sanroque

SLE

systemic lupus erythematosus

Sjögren's syndrome

SSA

Sjögren's syndrome-related Ag A

SSB

Sjögren's syndrome-related-related Ag B

Tfh

follicular helper T

Tfr

follicular regulatory T

wildtype

INTRODUCTION

Sjögren's syndrome (SS) is a chronic autoimmune disorder that is primarily characterized by lymphocytic infiltration into exocrine tissues such as salivary and lacrimal glands (1,2). Such epithelitis causes dysfunction of the glands and leads to sicca symptoms including dry mouth (xerostomia) and dry eyes (xerophthalmia). Numerous extra-glandular sites, such as lungs, skin, and thyroid, are also implicated. The primary form of SS involves disorders of the above organs without additional diseases. The secondary form is more common, and occurs in association with other rheumatic autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE or lupus) (3). In clinical studies, the prevalence of secondary SS among patients with SLE varied from 8% to 30% (4,5). Coexistence of SLE and SS appears to lead to a poor prognosis, since such patients suffered more often from peripheral vascular, renal, and musculoskeletal damage than those with SLE alone (6).

Although SS is second only to RA in prevalence among systemic autoimmune diseases (7), its pathogenesis is largely unknown. Since SLE is accompanied by SS in a substantial proportion of patients, SS and SLE may share some causal factors. An abundance of anti-nuclear Abs, especially IgG Ab to dsDNA, is a diagnostic feature of SLE (8). These autoantibodies are deposited in tissues as immune complexes, causing inflammation and end organ damage in skin, kidneys and more. It is widely accepted that long-lasting plasma cells producing high affinity, class-switched autoantibodies are mainly produced in germinal centers (GCs) inside the follicles of secondary lymphoid organs (9). The GC reaction is instructed by a specialized subset of CD4⁺ T cells, named follicular helper T (Tfh) cells (10). In this regard, Tfh cell-driven humoral immunity seems to be the main driver of SLE development. Like SLE, SS is also associated with an abundance of IgG autoantibodies, such as anti-SS-related Ag A (SSA)/Ro, anti-SS-related Ag B (SSB)/La, and anti-muscarinic receptor type 3 (M3R) Abs (11). Because M3R expression is restricted to exocrine gland tissues, anti-M3R Abs are thought to be specific for SS, while anti-SSA/Ro and anti-SSB/La Abs are also found in the sera of SLE patients (12). These findings suggest a pathogenic role of Tfh cell-driven Ab responses in the development of SS as well. This hypothesis is further supported by the fact that the frequency of circulating Tfh cells is increased in patients with primary SS (13) and that salivary gland epithelial cells from patients with SS promote the differentiation of Tfh cells (7). Nevertheless, whether dysregulation of Tfh cells is sufficient to trigger the development of SS remains uncertain.

In mice, the pathogenic role of Tfh cells in SLE occurring in a lupus-prone strain named sanroque (SAN) is well established. SAN mice are homozygous for the M199R “san” allele in the Roquin gene (Roquin^san/san), which encodes a member of the RING-type ubiquitin ligase family (14). As a consequence of overexpression of inducible T-cell costimulatory on T cells, SAN mice spontaneously develop excess Tfh cells with more numerous GCs than their wildtype (WT) littermates (15). High affinity anti-nuclear IgG autoantibodies can be detected in female SAN mice as early as the preclinical phase, and their appearance is followed by renal pathology typical of lupus. However, it is not known whether the autoimmunity occurring in SAN mice also affects exocrine glands and drives SS pathology.

This study was undertaken to determine whether hyper-activation of Tfh cells is sufficient to precipitate SS. To this end, we used SAN mice, and found that secondary SS-like manifestations occur spontaneously in aged SAN mice. Thus, our results provide evidence for a pathogenic role of Tfh cells in the development of SS and we propose SAN mice as a model of the coexistence of secondary SS and SLE.

MATERIALS AND METHODS

Mice

Heterozygotes for the M199R allele in the Roquin gene (Roquin^san/+) on a C57BL/6 background (14) were purchased from Mutant Mouse Regional Resource Center, University of California at Davis. They were bred to generate homozygous SAN (Roquin^san/san) mice in a specific pathogen-free barrier facility at Hanyang University. Female SAN mice and their WT littermates at 20–45 wk of age were used. This study was approved by the Institutional Animal Care and Use Committee (HY-IACUC-2016-0064 and HY-IACUC-2017-0198). All animal experiments were carried out in strict accordance with guidelines and regulations.

Saliva measurement

Mice were anesthetized and injected intraperitoneally with pilocarpine (Sigma-Aldrich, St. Louis, MO, USA) at a dose of 5 mg/kg body weight to induce saliva secretion. One min after injection, saliva was collected from the oral cavity for 5 min.

Histopathologic examination

Salivary glands and kidneys were fixed, embedded in paraffin and sectioned at 8 and 3 μm, respectively, as described previously (16). The tissue sections were stained with periodic acid-Schiff (Sigma-Aldrich) for kidneys, and with H&E (Sigma-Aldrich) for salivary glands. Histopathologic indexes were enumerated as described previously (17,18). In some experiments, tissue sections were stained with anti-mouse IgG-biotin (Sigma-Aldrich), followed by standard immunohistochemical methods, as described (19). Hematoxylin was used for counter staining.

FACS analysis

Spleen and cervical lymph node (cLN) cells from 35–40-wk-old mice were analyzed by FACS, as previously described (20). The following mAbs and reagents were purchased from BD Biosciences (San Jose, CA, USA) or eBioscience (San Diego, CA, USA): anti-CD4-PerCP, anti-Bcl6-FITC, anti-CXCR5-biotin, streptavidin-allophycocyanin (APC), anti-CD44-APC-Cy7, anti-GL7-FITC, anti-Fas-PE, anti-B220-PerCP, and anti-CD138-APC.

ELISA

Sera were collected from SAN mice and their WT littermates and assayed by ELISA to measure autoantibodies. The titers of anti-dsDNA and anti-M3R Abs were determined as described previously (16,21). Peptides encoding the murine M3R extracellular domain (VLVNTFCDSCIPKTYWNLGY) were synthesized by Peptron (Daejeon, Korea) and used at 10 μg/ml. Titers of total-IgG, anti-SSA/Ro and anti-SSB/La Abs were measured using Mouse Total IgG ELISA kit, Mouse Anti-SSA Total Ig kit, Mouse Anti-SSB Total Ig kit (all from Alpha Diagnostic International, San Antonio, TX, USA), respectively. To prepare salivary gland extracts, salivary glands were homogenized in PBS with protease inhibitors and spun down at 12,000 g for 30 min at 4^oC to collect supernatants. The salivary gland extracts were coated at 5 μg/ml onto the plates and standard ELISA methods were followed. A mouse serum containing the highest titer of autoantibodies was serially diluted and used as a standard.

ELISPOT assay

Ab-secreting cells were enumerated by standard ELISPOT methods, as described previously (22) with modifications. In brief, PVDF membrane filter plates (Merck Millipore, Burlington, MA, USA) were activated with 75% ethanol for 2 min and coated with appropriate Ags as in the above ELISA methods. Aliquots of cell suspensions from spleens and cLNs were added to the wells and incubated overnight at 37°C, followed by sequential incubation with biotinylated anti-mouse IgG mAb (Sigma-Aldrich) and alkaline phosphatase-conjugated streptavidin (Sigma-Aldrich). After adding NBT-BCIP (Mabtech AB, Nacka Strand, Sweden), spot numbers were counted using an iSpot Reader System (AID, Strassberg, Germany). Data are presented as numbers of Ab-secreting cells per 10⁵ cells with background subtracted.

RESULTS AND DISCUSSION

SAN mice exhibit manifestations of sialadenitis after the onset of lupus nephritis

SAN mice have been shown to spontaneously develop lupus-like symptoms in their kidneys with a variable time of onset depending on genetic background, sex, and environmental conditions (14,15). When we looked for lupus-like features in female SAN mice bred in our animal facility we found that all nephritic indexes, such as hypercellularity score, proportion of proliferating glomeruli, and lymphocytic infiltration, were significantly higher in the SAN mice than their WT littermates (Fig. 1A and B). This histopathology was evident by about 20 wk after birth (not shown) and was sustained until 40 wk after birth (Fig. 1A and B). Consistent with this, the kidneys (mostly the glomeruli) of SAN mice stained strongly with anti-IgG mAbs, indicative of IgG deposition, whereas those of their WT counterparts did not (Fig. 1C). These data confirm that SAN mice are bona fide mouse models of human lupus.

Figure 1

Clinical and histopathologic manifestations akin to lupus nephritis and SS in SAN mice. Female SAN mice and their WT littermates at 40–45 wk (A, B), 20 wk (C), and the indicated wk (D-F) of age were examined by clinical and histopathologic methods. (A) Kidney sections stained with periodic acid-Schiff. (B) Histopathologic indexes. (C) Immunohistochemical images of kidney sections stained with anti-mouse IgG mAb. (D) Saliva flow rates. (E) Salivary gland sections stained with H&E. Arrows indicate foci of lymphoid infiltrates. (F) Immunohistochemical images of salivary gland sections stained with anti-mouse IgG mAb. Photographs are representative of more than three individuals. Graphs display means±SEMs with symbols representing the values of individual mice.

HETERO, heterozygote; NS, not significant.

^*The p<0.05 by Student's t-test.

To determine whether the mechanisms leading to autoimmune defects in SAN mice also generate a disorder akin to SS, we carried out clinical and histopathologic examinations of the salivary glands. We found a significantly reduced rate of saliva flow in female SAN mice at 40–45 wk of age, indicative of dysfunction of the salivary glands (Fig. 1D). Moreover, salivary gland tissues from SAN mice, but not those from WT controls, contained foci composed of lymphocytic infiltrates as well as IgG deposits (Fig. 1E and F). Importantly, the histopathologic manifestations were not yet seen in the mice at the onset of lupus (about 20 wk) or even at the time of full-blown lupus (about 30 wk), while the extent of IgG deposits was slightly enhanced.

Taken together, these results demonstrate that SAN mice develop a secondary SS-like disorder. Given that the primary phenotype of SAN mice, this suggests that chronic over-activation of Tfh cells is sufficient to precipitate sialadenitis, leading to dysfunction of salivary glands. Interestingly, we found that the onset of SS is delayed by about 20 wk with respect to the onset of lupus. This leads us to speculate that factors other than Tfh cell-driven autoimmunity play a role in controlling when damage occurs to the salivary glands. Little is known about these factors, but it is likely that sex hormones whose concentrations vary with age are involved, and that the 2 diseases have different susceptibilities to these hormones. For example, estrogens have been shown to play pathogenic and protective roles in the pathogenesis of SLE and SS, respectively, in animal models (23-25). Clinical studies revealing that SLE and SS are common at childbearing age and in perimenopausal period, respectively (2,26) are in agreement with our results and further support the hypothesis.

The production of autoantibodies targeting salivary glands is enhanced in SAN mice from the preclinical phase

Since elevated titers of serum IgG autoantibodies are a hallmark of systemic autoimmune diseases and we have found IgG deposits in target tissues, we measured levels of autoantibodies specific for SLE (anti-dsDNA) and SS (anti-M3R) and of autoantibodies common to both diseases (anti-SSA/Ro and anti-SSB/La). We found that the serum titers of IgG-switched Abs to dsDNA and M3R, whole Abs to SSA/Ro and SSB/La, and whole IgG were significantly elevated in female SAN mice of 40–45 wk of age (Fig. 2A). IgG Abs reactive to salivary gland were also significantly more abundant in SAN mice. The increases in anti-M3R IgG as well as anti-dsDNA IgG were already prominent at 20 wk of age, the preclinical phase for SS, and were sustained until 30–35 wk of age (Fig. 2B). Cells secreting IgG Abs to M3R and salivary gland extracts were about 2-fold and 3–4-fold more numerous in the spleens and cLNs of SAN mice, respectively, than in those of WT counterparts (Fig. 2C). Anti-dsDNA IgG-secreting cells also showed similar trends, though lacking statistical significance.

Figure. 2

The spectrum of autoantibodies and frequencies of autoantibody-secreting cells in SAN mice. (A, B) Sera were collected from mice at 40–45 wk of age (A) and at the indicated ages (B), and assayed by ELISA. (C) ASCs in spleen and cervical LNs from 30–35-wk-old mice were counted in ELISPOT assays. Each symbol represents individual mice and horizontal lines display mean±SEM of each group.

AU, arbitrary units; ASC, Ab-secreting cell; NS, not significant; SGE, salivary gland extracts; Sp, spleen.

^*The p<0.05, ^**p<0.01 and ^***p<0.001 by Student's t-test.

These results together demonstrate that the lymph nodes (LNs) draining salivary glands are more active than spleens in producing autoantibodies targeting salivary glands prior to the emergence of tissue damage. Despite the later onset of sialadenitis compared to glomerulonephritis, signature autoantibodies for SS and for SLE are produced concurrently and with similar kinetics. Thus, the later onset of SS may not be due to delayed production of autoantibodies targeting salivary glands. Instead, protective mechanisms may exist that renders the salivary glands less vulnerable to damage by autoantibody-mediated inflammatory responses.

Our finding that SAN mice contain high titers of autoantibodies reactive to salivary gland extracts is intriguing, and may point to a perturbation of glandular homeostasis and breakdown of self-tolerance against glandular tissues. These two pathogenic events may form a positive feedback loop that amplifies destructive autoimmune processes. It is also worth noting that, unique among Abs specific for salivary glands, anti-M3R Ab has been shown to act as an antagonist to M3R in inhibiting acetylcholine signals, so reducing salivary secretion in addition to mediating inflammation (27). Therefore, the elevated anti-M3R Ab in SAN mice seems to play an important role in the development of the SS-like disorder.

The salivary gland-draining LNs in SAN mice contain elevated numbers of Tfh cells and their downstream effector cells

We hypothesized that in SAN mice an initial perturbation of glandular homeostasis causes autoantigens to be released from salivary gland tissue and to drain to adjacent LNs in which a Tfh cell-driven GC reaction takes place. We tested this idea by examining the cellular content of cLNs. As expected, CXCR5⁺Bcl6⁺ Tfh cells were more numerous in the cLNs of SAN mice than in those of WT mice (Fig. 3A). In agreement with this, the proportions and numbers of GL7⁺Fas⁺ GC B cells and B220⁻CD138⁺ plasma cells were significantly elevated in the cLNs of SAN mice (Fig. 3B and C). These effects were also seen in their spleens and mesenteric LNs but were less pronounced (Fig. 3A and Supplementary Fig. 1), suggesting that the sialadenitis seen in aged SAN mice is due to enhanced GC responses occurring predominantly in salivary gland-draining LNs. Intriguingly, LNs pooled out from axillary, inguinal and popliteal sites contained Tfh cells at the level comparable to cLNs (Supplementary Fig. 1). We suspect that this is due to axillary LNs that are involved in the immune network for sialadenitis as well. We also cannot rule out the possibility that paw joints are sites susceptible to the immune attack associated with SAN phenotypes.

Figure. 3

FACS profiles of humoral immune cells associated with GC in SAN mice. Humoral immune cells in SAN mice and their WT littermates at 30–35 wk of age were assayed post mortem by FACS. Representative FACS profiles gated on CD4⁺CD44^high cells (A), B220⁺ cells (B), viable lymphocytes (C) and CD4⁺ cells (D) are shown in the left panels. Graphs displaying percentages or cell numbers are presented in the right panels. All data are representative of more than 3 independent experiments.

NS, not significant; Sp, spleen.

^*The p<0.05, ^**p<0.01, and ^***p<0.001 by Student's t-test.

Enhanced GC responses including differentiation of GC B cells and plasma cells could be influenced by follicular regulatory T (Tfr) cells, a subset of forkhead box P3 (Foxp3⁺) Tregs residing in GCs and expressing CXCR5 and Bcl6, given that a lack of Tfr cells led to greater GC responses (28). To address this possibility, we detected CD4⁺CXCR5⁺Foxp3⁺ Tfr cells in SAN mice and found that the proportion and number of Tfr cells were not decreased in spleens and cLNs from SAN mice when compared with those from WT mice (Fig. 3D). This suggests that Tfr cells may not be dysregulated in a way that has been previously appreciated to cause GC activation. Although there were previous studies showing elevated number of whole Treg cells (CD4⁺Foxp3⁺ cells) in 8–10-wk-old SAN mice (29,30), it is worth noting that our data reveal for the first time the irrelevance of SAN's SS-like pathogenesis with the Tfr subset that is actually functional inside the follicle.

In summary, we provide clear evidence for the spontaneous development of secondary SS in SAN mice. Humoral autoimmunity driven by hyperactivated Tfh cells in salivary gland-draining LNs appears to be responsible for this previously unappreciated phenotype. Thus, our findings suggest that chronically dysregulated activity of Tfh cells is sufficient to induce the delayed development of secondary SS in lupus-prone mice.

Abbreviations

APC

allophycocyanin

cLN

cervical lymph node

Foxp3⁺

forkhead box P3

germinal center

lymph node

M3R

muscarinic receptor type 3

rheumatoid arthritis

SAN

sanroque

SLE

systemic lupus erythematosus

Sjögren's syndrome

SSA

Sjögren's syndrome-related Ag A

SSB

Sjögren's syndrome-related-related Ag B

Tfh

follicular helper T

Tfr

follicular regulatory T

wildtype

ACKNOWLEDGMENTS

We thank the Analytical Instrumental Center (Seoul) at Hanyang University for technical support. This work was supported by grants funded by the Korean Health Technology R&D Project, Ministry of Health & Welfare, Korea (HI13C0016 and HI17C1103).

Notes

^{Conflict of Interest} The authors declare no potential conflicts of interest.

^{Author Contributions}

Conceptualization: Youn J.
Data curation: Youn J, Choi SS, Jang E.
Formal analysis: Choi SS, Jang E, Jang K.
Funding acquisition: Youn J, Park SH.
Investigation: Choi SS, Jang E, Oh YK.
Methodology: Jang E, Oh YK.
Resources: Cho ML.
Supervision: Youn J.
Validation: Jang K.
Writing - original draft: Choi SS.
Writing - review & editing: Youn J.

References

1. Sandhya P, Kurien BT, Danda D, Scofield RH. Update on pathogenesis of Sjögren's syndrome. Curr Rheumatol Rev. 2017; 13:5–22.

2. Maślińska M, Przygodzka M, Kwiatkowska B, Sikorska-Siudek K. Sjögren's syndrome: still not fully understood disease. Rheumatol Int. 2015; 35:233–241.

3. Gilboe IM, Kvien TK, Uhlig T, Husby G. Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis. 2001; 60:1103–1109.

4. Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, Moutsopoulos HM. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum. 2004; 50:882–891.

5. Alani H, Henty JR, Thompson NL, Jury E, Ciurtin C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018; 47:141–154.

6. Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS. J Rheumatol. 1998; 25:63–68.

7. Gong YZ, Nititham J, Taylor K, Miceli-Richard C, Sordet C, Wachsmann D, Bahram S, Georgel P, Criswell LA, Sibilia J, et al. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome. J Autoimmun. 2014; 51:57–66.

8. Malkiel S, Barlev AN, Atisha-Fregoso Y, Suurmond J, Diamond B. Plasma cell differentiation pathways in systemic lupus erythematosus. Front Immunol. 2018; 9:427.

9. Kelsoe G. The germinal center reaction. Immunol Today. 1995; 16:324–326.

10. Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014; 41:529–542.

11. Tong L, Koh V, Thong BY. Review of autoantigens in Sjögren's syndrome: an update. J Inflamm Res. 2017; 10:97–105.

12. Fayyaz A, Kurien BT, Scofield RH. Autoantibodies in Sjögren's syndrome. Rheum Dis Clin North Am. 2016; 42:419–434.

13. Li XY, Wu ZB, Ding J, Zheng ZH, Li XY, Chen LN, Zhu P. Role of the frequency of blood CD4⁺CXCR5⁺CCR6⁺ T cells in autoimmunity in patients with Sjögren's syndrome. Biochem Biophys Res Commun. 2012; 422:238–244.

14. Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, Yu D, Domaschenz H, Whittle B, Lambe T, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature. 2005; 435:452–458.

15. Yu D, Tan AH, Hu X, Athanasopoulos V, Simpson N, Silva DG, Hutloff A, Giles KM, Leedman PJ, Lam KP, et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature. 2007; 450:299–303.

16. Jang E, Jeong M, Kim S, Jang K, Kang BK, Lee DY, Bae SC, Kim KS, Youn J. Infusion of human bone marrow-derived mesenchymal stem cells alleviates autoimmune nephritis in a lupus model by suppressing follicular helper T-cell development. Cell Transplant. 2016; 25:1–15.

17. Schena F, Gambini C, Gregorio A, Mosconi M, Reverberi D, Gattorno M, Casazza S, Uccelli A, Moretta L, Martini A, et al. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum. 2010; 62:2776–2786.

18. Chang JW, Hung SP, Wu HH, Wu WM, Yang AH, Tsai HL, Yang LY, Lee OK. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant. 2011; 20:245–257.

19. Cho WS, Jang E, Kim HY, Youn J. Interleukin 17-expressing innate synovial cells drive K/Bxn serum-induced arthritis. Immune Netw. 2016; 16:366–372.

20. Jang E, Cho WS, Oh YK, Cho ML, Kim JM, Paik DJ, Youn J. Splenic long-lived plasma cells promote the development of follicular helper T cells during autoimmune responses. J Immunol. 2016; 196:1026–1035.

21. Lin X, Rui K, Deng J, Tian J, Wang X, Wang S, Ko KH, Jiao Z, Chan VS, Lau CS, et al. Th17 cells play a critical role in the development of experimental Sjögren's syndrome. Ann Rheum Dis. 2015; 74:1302–1310.

22. Jang E, Cho WS, Cho ML, Park HJ, Oh HJ, Kang SM, Paik DJ, Youn J. Foxp3⁺ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells. J Immunol. 2011; 186:1546–1553.

23. Grimaldi CM, Michael DJ, Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol. 2001; 167:1886–1890.

24. Shim GJ, Warner M, Kim HJ, Andersson S, Liu L, Ekman J, Imamov O, Jones ME, Simpson ER, Gustafsson JA. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjögren's syndrome. Proc Natl Acad Sci U S A. 2004; 101:12628–12633.

25. Ciháková D, Talor MV, Barin JG, Baldeviano GC, Fairweather D, Rose NR, Burek CL. Sex differences in a murine model of Sjögren's syndrome. Ann N Y Acad Sci. 2009; 1173:378–383.

26. Knight CL, Nelson-Piercy C. Management of systemic lupus erythematosus during pregnancy: challenges and solutions. Open Access Rheumatol. 2017; 9:37–53.

27. Yu X, Riemekasten G, Petersen F. Autoantibodies against muscarinic acetylcholine receptor M₃ in Sjögren's syndrome and corresponding mouse models. Front Biosci (Landmark Ed). 2018; 23:2053–2064.

28. Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, Rawal S, Wang YH, Lim H, Reynolds JM, Zhou XH, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med. 2011; 17:983–988.

29. Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, Cannons JL, Schwartzberg PL, Cook MC, Walters GD, Vinuesa CG. Follicular helper T cells are required for systemic autoimmunity. J Exp Med. 2009; 206:561–576.

30. Lee SK, Silva DG, Martin JL, Pratama A, Hu X, Chang PP, Walters G, Vinuesa CG. Interferon-γ excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity. 2012; 37:880–892.

SUPPLEMENTARY MATERIAL

Supplementary Fig. 1

Frequencies of Tfh cells in diverse LNs of SAN mice. Cells from cLNs, mesenteric lymph nodes (mLNs) and peripheral lymph nodes (pLNs; a mixture of axillary, inguinal and popliteal LNs) of SAN mice and their WT littermates at 38–40 wk of age were assayed post mortem by FACS. Representative FACS profiles gated on CD4⁺ cells are shown in the left panels. Graphs displaying percentages or cell numbers are presented in the right panels.

TOOLS

ORCID iDs

Suk San Choi
https://orcid.org/0000-0001-9400-2733

Mi-La Cho
https://orcid.org/0000-0001-5715-3989

Jeehee Youn
https://orcid.org/0000-0003-1644-6843

Similar articles